ACTRN12620000082909已完成未知
Establishment of an insulin dosing schedule for high fat, high protein meals in individuals with type 1 diabetes using insulin pump therapy.
Australasian Paediatric Endocrine Group0 个研究点目标入组 27 人开始时间: 2020年1月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 8 Years 至 25 Years（—）
- 性别
- All
入选标准
- •T1DM for more than 1 year
- •Using insulin pump therapy
- •HbA1c less than or equal to 64 mmol/mol (8.0%)
- •Body mass index less than the 95th percentile
排除标准
- •Coexisting medical problems
- •Evidence of complications of diabetes incl gastroparesis
- •Dietary restrictions (allergies/ intolerances) that prevent test meal consumption
研究者
相似试验
已完成
不适用
Insulin dosing for fat and protein in people with Type 1 Diabetes using insulin injections.Diet and Nutrition - Other diet and nutrition disordersMetabolic and Endocrine - DiabetesType 1 DiabetesACTRN12618002030257Diabetes Australia27
已完成
不适用
The study of algorithm for insulin dose after the change to insulin glargine U300 (LANTUS-XR) for type 2 diabetic patients with poor glucose control under insulin therapy.Type 2 diabetes mellitusJPRN-UMIN000024738Matsuyama shimin hospital100
未知
不适用
Investigation optimal dosing of insulin detemir after switching from other basal insulin by using CGM systemDiabetesJPRN-UMIN000002267Tokyo Women's Medical University20
已完成
不适用
What is the optimal dose of insulin for the protein content of a meal in individuals with type 1 diabetes mellitus using intensive insulin therapyType 1 Diabetes MellitusACTRN12616000222448Hunter Medical Research Institute32
已完成
Unknown
Artificial intelligence (AI)-powered mealtime insulin dose-assisted decision-making systemType 2 diabetesNutritional, Metabolic, EndocrineISRCTN16784568Peking University People's Hospital111